Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide

References

• Becker B. (1954). Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol, 37:13–5.
   PubMed Web of Science ®Google Scholar
• El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm, 158:121–7.
   Web of Science ®Google Scholar
• Zimmerman TJ. (1978). Acetazolamide and methazolamide. Ann Ophthalmol, 10:509–10.
   Web of Science ®Google Scholar
• Angela CP. (1990). Stable ophthalmic composition comprising methazolamide. UK patent no. 2223166 A.
   Google Scholar
• Hurvitz LM, Kaufman PL, Robin AL, Weinreb RN, Crawford K, Shaw B. (1991). New developments in the drug treatment of glaucoma. Drugs, 41:514–32.
   PubMed Web of Science ®Google Scholar
• Fridriksdóttir H, Loftsson T, Stefánsson E. (1997). Formulation and testing of methazolamide cyclodextrin eye drop solutions. J Control Release, 44:95–9.
   Web of Science ®Google Scholar
• Srividya B, Cardoza RM, Amin PD. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release, 73:205–11.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular delivery: An overview. Int J Pharm, 269:1–14.
   PubMed Web of Science ®Google Scholar
• Middletion DL, Leung SS, Robinson JR. (1990). Ocular bioadhhesive delivery systems. In: Lenaerts V, Gurny R, eds. Bioadhesive drug delivery systems. Boca Raton, FL: CRC Press, 179–202.
   Google Scholar
• Qi HY, Chen WW, Huang CT, Li L, Chen CM, Li WM, . (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm, 337:178–87.
   PubMed Web of Science ®Google Scholar
• Liu ZD, Li JW, Nie SF, Liu H, Ding PT, Pan WS. (2006). Study of alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm, 315:12–7.
   PubMed Web of Science ®Google Scholar
• Mansour M, Mansour S, Mortada ND, Abd Elhady SS. (2008). Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels. Drug Dev Ind Pharm, 34:744–52.
   PubMed Web of Science ®Google Scholar
• Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, Rotonda MIL. (2008). A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: Rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm, 70:199–206.
   PubMed Web of Science ®Google Scholar
• Wei G, Xu H, Ding PT, Li SM, Zheng JM. (2002). Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J Control Release, 83:65–74.
   PubMed Web of Science ®Google Scholar
• Gilbert JC, Richardson JL, Martyn CD, Palin KJ. (1987). The effect of solutes and polymers on the gelation properties of pluronic–F127 solutions for controlled drug delivery. J Control Release, 5:113–8.
   Google Scholar
• Kim EY, Gao ZG, Park JS, Li H, Han K. (2002). rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm, 233:159–67.
   PubMed Web of Science ®Google Scholar
• Chen E, Chen J, Cao SL, Zhang QZ, Jiang XG. (2010). Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm, 36:490–6.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang XG, Li X, Pan W, Li J. (2007). Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev Ind Pharm, 33:1327–31.
   PubMed Web of Science ®Google Scholar
• Lederer CM Jr, Harold RE. (1986). Drop size of commercial glaucoma medications. Am J Ophthalmol, 101:691–4.
   PubMed Web of Science ®Google Scholar
• Hagerstrom H, Paulsson M, Edsman K. (2000). Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci, 9:301–9.
   PubMed Web of Science ®Google Scholar
• Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. (1998). Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm, 165:33–44.
   Web of Science ®Google Scholar
• Vadnere M, Amidon G, Lindenbaum S, Haslam JL. (1984). Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm, 22:207–18.
   Web of Science ®Google Scholar
• Wu CJ, Qi HY, Chen WW, Huang CY, Su C, Li WM, . (2007). Preparation and evaluation of a carbopol®/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi, 127:183–91.
   PubMed Web of Science ®Google Scholar
• Edsman K, Carlfors J, Petersson R. (1998). Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci, 6:105–12.
   PubMed Web of Science ®Google Scholar
• Lin HR, Sung KC. (2000). Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release, 69:379–88.
   PubMed Web of Science ®Google Scholar